Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 12 | 2024 | 2332 | 1.440 |
Why?
|
| Struma Ovarii | 1 | 2022 | 10 | 0.830 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2023 | 125 | 0.820 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2021 | 141 | 0.740 |
Why?
|
| Hernia, Hiatal | 3 | 2023 | 90 | 0.580 |
Why?
|
| Thyroidectomy | 6 | 2023 | 908 | 0.500 |
Why?
|
| Gastroesophageal Reflux | 4 | 2022 | 819 | 0.480 |
Why?
|
| Iodine Radioisotopes | 4 | 2023 | 1031 | 0.390 |
Why?
|
| Laparoscopy | 4 | 2023 | 2036 | 0.360 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.340 |
Why?
|
| Gene Expression | 1 | 2021 | 7581 | 0.310 |
Why?
|
| Carcinoma, Papillary | 2 | 2023 | 785 | 0.290 |
Why?
|
| Neuroendocrine Tumors | 2 | 2022 | 641 | 0.260 |
Why?
|
| Immunotherapy | 1 | 2021 | 4652 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4878 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8554 | 0.250 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7859 | 0.230 |
Why?
|
| Zenker Diverticulum | 1 | 2023 | 28 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2023 | 5882 | 0.210 |
Why?
|
| Cholecystitis, Acute | 1 | 2022 | 75 | 0.190 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 1277 | 0.190 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 136 | 0.190 |
Why?
|
| Esophagoscopy | 1 | 2023 | 396 | 0.190 |
Why?
|
| Gallbladder Diseases | 1 | 2022 | 141 | 0.190 |
Why?
|
| Parathyroidectomy | 1 | 2023 | 242 | 0.190 |
Why?
|
| Pathology, Surgical | 1 | 2022 | 151 | 0.190 |
Why?
|
| HLA-DQ Antigens | 1 | 2021 | 191 | 0.180 |
Why?
|
| Malpractice | 1 | 2023 | 556 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2023 | 572 | 0.150 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 1803 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2023 | 764 | 0.130 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 625 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 5368 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 1117 | 0.120 |
Why?
|
| Retrospective Studies | 13 | 2024 | 80647 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2022 | 818 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2023 | 1796 | 0.110 |
Why?
|
| Esophageal Sphincter, Lower | 2 | 2022 | 26 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2330 | 0.100 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 1188 | 0.100 |
Why?
|
| Fundoplication | 2 | 2022 | 144 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 2373 | 0.090 |
Why?
|
| Calcium | 1 | 2023 | 5722 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2021 | 1940 | 0.090 |
Why?
|
| Esophagogastric Junction | 2 | 2022 | 347 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9542 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4369 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 16990 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2023 | 3816 | 0.070 |
Why?
|
| Humans | 21 | 2024 | 761596 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 6345 | 0.060 |
Why?
|
| Prognosis | 2 | 2023 | 29629 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5440 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64685 | 0.050 |
Why?
|
| Diaphragm | 1 | 2022 | 351 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2022 | 23996 | 0.050 |
Why?
|
| Gallbladder | 1 | 2022 | 308 | 0.050 |
Why?
|
| Female | 9 | 2024 | 392705 | 0.040 |
Why?
|
| Manometry | 1 | 2022 | 454 | 0.040 |
Why?
|
| Chemokines | 1 | 2022 | 959 | 0.040 |
Why?
|
| Medicaid | 2 | 2021 | 2818 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2024 | 7968 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 81539 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 672 | 0.040 |
Why?
|
| Middle Aged | 7 | 2024 | 220921 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2021 | 1784 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2021 | 836 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2023 | 41495 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2022 | 874 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 2915 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9280 | 0.030 |
Why?
|
| Mutation | 3 | 2023 | 30053 | 0.030 |
Why?
|
| Adult | 6 | 2024 | 221210 | 0.030 |
Why?
|
| Aged | 5 | 2024 | 169310 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2023 | 1979 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2057 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2725 | 0.030 |
Why?
|
| Reoperation | 1 | 2023 | 4303 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 168475 | 0.030 |
Why?
|
| Male | 7 | 2024 | 360846 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2022 | 6484 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
| United States | 3 | 2024 | 72340 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3878 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5305 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5672 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3358 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8225 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10194 | 0.020 |
Why?
|
| Medicare | 1 | 2021 | 6770 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15633 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23447 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 59260 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80158 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 88326 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_